TPG-led group to buy U.S. health services provider Chindex for $369 mln
Feb 17 (Reuters) - A group led by private equity firm TPG will buy Chindex International Inc, a U.S. healthcare provider in China, for $369 million, Chindex said on Monday.
TPG and the other buyers - an affiliate of Shanghai Fosun Pharmaceutical Group and Chindex Chief Executive Roberta Lipson - will buy all of Chindex's outstanding common shares for $19.50 per share in cash, 13.7 percent above the shares' closing price on Nasdaq on Friday.
Chindex, which provides its services via the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, said it expects the deal to close in the second half of 2014.
- U.S. air strikes on Syria would face formidable obstacles
- Samsung unveils smartwatch that can make calls
- Ukraine leader says Russian forces are in the country as key town falls
- FBI, Secret Service investigate reports of cyber attacks on U.S. banks
- Breakthrough hopes dented as Ukraine accuses Russia of new incursion |